» Articles » PMID: 9006003

Podocyte Loss and Progressive Glomerular Injury in Type II Diabetes

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1997 Jan 15
PMID 9006003
Citations 439
Authors
Affiliations
Soon will be listed here.
Abstract

Kidney biopsies from Pima Indians with type II diabetes were analyzed. Subjects were classified clinically as having early diabetes (n = 10), microalbuminuria (n = 17), normoalbuminuria, despite a duration of diabetes equal to that of the subjects with microalbuminuria (n = 12), or clinical nephropathy (n = 12). Subjects with microalbuminuria exhibited moderate increases in glomerular and mesangial volume when compared with those with early diabetes, but could not be distinguished from subjects who remained normoalbuminuric after an equal duration of diabetes. Subjects with clinical nephropathy exhibited global glomerular sclerosis and more prominent structural abnormalities in nonsclerosed glomeruli. Marked mesangial expansion was accompanied by a further increase in total glomerular volume. Glomerular capillary surface area remained stable, but the glomerular basement membrane thickness was increased and podocyte foot processes were broadened. Broadening of podocyte foot processes was associated with a reduction in the number of podocytes per glomerulus and an increase in the surface area covered by remaining podocytes. These findings suggest that podocyte loss contributes to the progression of diabetic nephropathy.

Citing Articles

Podocyturia an emerging biomarker for kidney injury.

Hanna C, Etry H, Ibrahim M, Khalife L, Bahous S, Faour W BMC Nephrol. 2025; 26(1):118.

PMID: 40045253 PMC: 11884025. DOI: 10.1186/s12882-025-04039-w.


RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease.

Guo Z, Gao S, Xu F, Chen Z, Wang Q, Liu Z J Nanobiotechnology. 2025; 23(1):81.

PMID: 39905421 PMC: 11792197. DOI: 10.1186/s12951-025-03108-4.


Acute hyperglycemia induces podocyte apoptosis by monocyte TNF-α release, a process attenuated by vitamin D and GLP-1 receptor agonists.

Zhang R, Oh J, Wice B, Dusso A, Bernal-Mizrachi C J Steroid Biochem Mol Biol. 2025; 247:106676.

PMID: 39818342 PMC: 11859504. DOI: 10.1016/j.jsbmb.2025.106676.


A human stem cell-derived model reveals pathologic extracellular matrix remodeling in diabetic podocyte injury.

Roye Y, Miller C, Kalejaiye T, Musah S Matrix Biol Plus. 2024; 24:100164.

PMID: 39582511 PMC: 11585791. DOI: 10.1016/j.mbplus.2024.100164.


Role and Mechanisms of Tyro3 in Podocyte Biology and Glomerular Disease.

Min L, Chen Y, Zhong F, Gu L, Lee K, He J Kidney Dis (Basel). 2024; 10(5):398-406.

PMID: 39430290 PMC: 11488836. DOI: 10.1159/000540452.


References
1.
Kroustrup J, Gundersen H, Osterby R . Glomerular size and structure in diabetes mellitus. III. Early enlargement of the capillary surface. Diabetologia. 1977; 13(3):207-10. DOI: 10.1007/BF01219701. View

2.
Pagtalunan M, Oberbauer R, Haas M, Barlan M, Mayer G, Olson J . Atubular glomeruli in patients with chronic allograft rejection. Transplantation. 1996; 61(8):1166-71. DOI: 10.1097/00007890-199604270-00008. View

3.
Osterby R, Gundersen H . Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy. Diabetologia. 1980; 18(6):493-500. DOI: 10.1007/BF00261706. View

4.
Hostetter T, Troy J, Brenner B . Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 1981; 19(3):410-5. DOI: 10.1038/ki.1981.33. View

5.
MAUER S, Steffes M, Ellis E, Sutherland D, Brown D, Goetz F . Structural-functional relationships in diabetic nephropathy. J Clin Invest. 1984; 74(4):1143-55. PMC: 425280. DOI: 10.1172/JCI111523. View